M&T Bank’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
M&T Bank's IRMD Position: Q3 2026 in Review
M&T Bank reduced its iRadimed (IRMD) stake by 23% in Q3 2026, selling an estimated $82.1K and leaving 2,982 shares worth $257K. The position accounts for ﹤0.01% of the portfolio, ranked #1521.
M&T Bank first reported a position in IRMD in Q1 2026 and has held it in 3 quarters since. The position peaked at $641K in Q1 2026. 215 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.
- M&T Bank held 2,982 shares of iRadimed worth $257K as of Q3 2026.
- M&T Bank sold 914 iRadimed shares in Q3 2026, an estimated $82.1K.
- iRadimed made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1521 holding.
- M&T Bank first reported a position in iRadimed in Q1 2026 and has held it in 3 quarters since.
- M&T Bank's iRadimed position peaked at $641K in Q1 2026.
- 215 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.
Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.